Cancer Clinical Academic Group news:

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100,000 in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021.

Congratulations to the successful awardees and their teams.

Increasing the efficacy of brain cancer treatment traditionally requires access to tissue samples that can shed light on a tumour’s genetic makeup. But, with many malignancies buried deep inside essential areas of the brain, this tissue is often impossible to reach.

A new research project led by Associate Professor Therese Becker of the Ingham Institute is aiming to solve this problem. Using ‘liquid biopsies’ – that is, blood tests – the researchers hope to reveal critical information about individual patient tumours. 

A partnership between the Pancreatic Cancer Research Hub (PCRH) and the Molecular Screening and Therapeutics (MoST) trial in Sydney could help improve the poor survival rates of pancreatic cancer. 

At a recent Medical Technology Workshop, experts shared their perspectives on the challenges of bringing ideas to commercial and clinical fruition - exploring all aspects of medical technology development and commercialisation.

The Cancer Clinical Academic Group Management Committee has increased its consumer and community membership to three people. This recent change acknowledges the value of different perspectives and how lived experiences can strengthen the quality and relevance of health and medical research.

At the Therapeutic Development Workshop, experts shared perspectives on the challenges of moving a therapy from basic research discovery to the clinic - exploring all stages of therapeutic development.